Tag Archives: remdesivir

Fresh studies give more information about what treatments do or don’t work for COVID-19, with high-quality methods that give reliable results. British researchers on Friday published their research on the only drug shown to improve survival — a cheap steroid called dexamethasone. Two other studies found that malaria drug hydroxychloroquine …

Gilead Sciences, Inc., said on Friday additional data from a late-stage study showed its antiviral remdesivir significantly improved clinical recovery in severely ill COVID-19 patients. Findings from an analysis of its late-stage study showed that 74.4 percent of remdesivir-treated patients recovered by day 14 versus 59 percent of patients receiving …

The European Commission has struck deals with drugmakers Roche and Merck KGaA to secure supplies of experimental treatments for COVID-19, a Commission source told Reuters on Wednesday. The deals cover Roche’s arthritis medicine RoActemra and Merck’s multiple sclerosis drug Rebif – both seen as potential treatments for COVID-19 – and …

Officials in Brussels have approved remdesivir to treat severe cases of Covid-19, just days after the US effectively stockpiled the world’s entire supply of the antiviral medication. “We will leave no stone unturned in our efforts to secure efficient treatments or vaccine against the coronavirus,” EU health commissioner Stella Kyriakides …

The Trump administration has bought up virtually the entire stock for the next three months of one of the drugs proven to work against Covid-19, leaving none for the UK, Europe, or most of the rest of the world. On Monday the US Department of Health and Human Services (HSS) …

China-linked hackers are breaking into American organizations carrying out research into COVID-19, U.S. officials said on Wednesday, warning both scientists and public health officials to be on the lookout for cyber theft. In a joint statement, the Federal Bureau of Investigation and the Department of Homeland Security said the FBI …

Japan on Thursday approved Gilead Sciences Inc’s remdesivir as a treatment for COVID-19, making it the country’s first officially authorized drug to tackle the coronavirus disease. Japan reached the decision just three days after the U.S. drugmaker filed for fast-track approval for the treatment. “There has so far been no …

The Food and Drug Administration (FDA) plans to authorize the emergency use of remdesivir to treat those infected with the coronavirus. The experimental antiviral drug is being tested on patients as a treatment for Covid-19. Both Dr. Anthony Fauci and President Donald Trump have expressed optimism about early results from …

Wall Street looked set to jump at open on Wednesday after Gilead Sciences (GILD.O) reported an encouraging update on a potential COVID-19 treatment, while upbeat earnings reports from Google-parent Alphabet and Boeing boosted the mood. Gilead Sciences Inc (GILD.O) jumped 9.3% in premarket trading after the drugmaker said its experimental …

Stock markets struggled on Friday as hopes of quickly finding a treatment for coronavirus were dashed, analysts said, and more crushing economic data delivered a body blow to confidence. Reports said initial trials of the remdesivir coronavirus drug being developed by Gilead Sciences had flopped. Investors were “reacting badly” to …

COVID-19 patients who are getting an experimental drug called remdesivir have been recovering quickly, with most going home in days, STAT News reported Thursday after it obtained a video of a conversation about the trial. The patients taking part in a clinical trial of the drug have all had severe …